Yaxian Yao
No. 241 West Huaihai Road
Huaihai, 200030, China
Huaihai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.
Journal: Nature microbiology
Published: June 16, 2026
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.
Journal: Nature microbiology
Published: March 23, 2025
Sublobar resection for lung adenocarcinoma less than 2 cm containing solid or micropapillary components radiologically presented as consolidation-to-tumor ratio (CTR) ≤0.25 [ground-glass opacity (GGO)].
Journal: Translational lung cancer research
Published: March 10, 2024
Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer.
Journal: Frontiers in immunology
Published: July 27, 2023
Analysis for discharge within 2 days after thoracoscopic anatomic lung cancer surgery.
Journal: Cancer medicine
Published: August 20, 2022
An open, observational, three-arm clinical study of 2-3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis.
Journal: Frontiers in immunology
Published: May 07, 2022
Early-like differentiation status of systemic PD-1+CD8+ T cells predicts PD-1 blockade outcome in non-small cell lung cancer.
Journal: Clinical & translational immunology
Published: October 18, 2021
Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer.
Journal: Frontiers in immunology
Published: August 16, 2021
Convergent alteration of lung tissue microbiota and tumor cells in lung cancer.
Journal: iScience
Published: May 21, 2021
Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer.
Journal: Frontiers in molecular biosciences
Published: March 10, 2021
Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer.
Journal: Science China. Life sciences
Published: October 26, 2020
Last Updated: 09/26/2026